1. Home
  2. TK vs SGP Comparison

TK vs SGP Comparison

Compare TK & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teekay Corporation

TK

Teekay Corporation

HOLD

Current Price

$12.00

Market Cap

937.1M

ML Signal

HOLD

SGP

SpyGlass Pharma Inc. Common Stock

N/A

Current Price

$22.52

Market Cap

932.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TK
SGP
Founded
1973
2019
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
937.1M
932.9M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
TK
SGP
Price
$12.00
$22.52
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$45.00
AVG Volume (30 Days)
544.1K
100.8K
Earning Date
05-06-2026
03-26-2026
Dividend Yield
16.88%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.43
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.65
$22.41
52 Week High
$13.76
$30.56

Technical Indicators

Market Signals
Indicator
TK
SGP
Relative Strength Index (RSI) 54.04 31.50
Support Level $9.11 N/A
Resistance Level $13.76 $29.83
Average True Range (ATR) 0.43 1.78
MACD -0.02 -0.39
Stochastic Oscillator 62.56 10.49

Price Performance

Historical Comparison
TK
SGP

About TK Teekay Corporation

Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.

About SGP SpyGlass Pharma Inc. Common Stock

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Share on Social Networks: